Results 21 to 30 of about 134 (76)

Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial. [PDF]

Lancet Rheumatol, 2022
CORIMUNO-19 Collaborative group.
europepmc   +1 more source

Characteristics and prognosis of bloodstream infection in patients with COVID-19 admitted in the ICU: an ancillary study of the COVID-ICU study. [PDF]

Ann Intensive Care, 2021
Massart N, Maxime V, Fillatre P, Razazi K, Ferré A, Moine P, Legay F, Voiriot G, Amara M, Santi F, Nseir S, Marque-Juillet S, Bounab R, Barbarot N, Bruneel F, Luyt CE, COVID ICU Bacteremia Study Group on behalf of the COVID-ICU Investigators.   +16 more
europepmc   +1 more source

Benefits and risks of noninvasive oxygenation strategy in COVID-19: a multicenter, prospective cohort study (COVID-ICU) in 137 hospitals. [PDF]

Crit Care, 2021
COVID-ICU group, for the REVA network, COVID-ICU investigators.   +2 more
europepmc   +1 more source

Predicting 90-day survival of patients with COVID-19: Survival of Severely Ill COVID (SOSIC) scores. [PDF]

Ann Intensive Care, 2021
Schmidt M, Guidet B, Demoule A, Ponnaiah M, Fartoukh M, Puybasset L, Combes A, Hajage D, COVID-ICU Investigators.   +8 more
europepmc   +1 more source

Relationship between negative-pressure ICU rooms and the risk of COVID-19-associated pulmonary aspergillosis: an ancillary analysis of the COVID-ICU cohort study. [PDF]

Crit Care
Kreitmann L, Rouzé A, Luyt CE, Razazi K, Fartoukh M, Bruneel F, Gouzien L, Maxime V, Le Terrier C, Zahar JR, Béhal H, Nseir S, COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators.   +12 more
europepmc   +1 more source

Characteristics, management, and prognosis of elderly patients with COVID-19 admitted in the ICU during the first wave: insights from the COVID-ICU study : Prognosis of COVID-19 elderly critically ill patients in the ICU. [PDF]

Ann Intensive Care, 2021
Dres M, Hajage D, Lebbah S, Kimmoun A, Pham T, Béduneau G, Combes A, Mercat A, Guidet B, Demoule A, Schmidt M, COVID-ICU investigators.   +11 more
europepmc   +1 more source

PEEP-AKI-COVID ICU: Effect of positive end-expiratory pressure on acute kidney injury development in patients with COVID-19-associated acute respiratory distress syndrome: an ancillary analysis of the COVID-ICU study. [PDF]

J Intensive Care
Poirot L, Tchatat Wangueu L, Breteau I, Petit M, Schmidt M, Bavozet F, COVID ICU Group on behalf of the REVA Network and the COVID-ICU Investigators.   +6 more
europepmc   +1 more source

Factors associated with adverse haemodynamic events during the STARRT-AKI trial: a post-hoc secondary analysis. [PDF]

Crit Care
Kelly YP, da Costa BR, Beaubien-Souligny W, Clark EG, Murray PT, Nichol A, Wald R, Bagshaw SM, STandard vs. Accelerated initiation of Renal ReplacementTherapy in Acute Kidney Injury (STARRT-AKI) Investigators.   +8 more
europepmc   +1 more source

Risk of SARS-CoV-2 infection in healthcare workers with inflammatory bowel disease: a case-control study. [PDF]

Infect Prev Pract, 2023
Amiot A, Bourrier A, Gornet JM, Dewit O, Nancey S, Altwegg R, Abitbol V, Laharie D, Reenaers C, Gagnière C, Buisson A, Nachury M, Viennot S, Vuitton L, Stefanescu C, Marteau P, Bouguen G, Seksik P, GETAID-INFOPRO study group.   +18 more
europepmc   +1 more source

Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial. [PDF]

Lancet Respir Med, 2021
CORIMUNO-19 Collaborative group.
europepmc   +1 more source